close 74% rachunków inwestorów detalicznych odnotowuje straty w wyniku handlu kontraktami CFD u niniejszego dostawcy. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 74% rachunków inwestorów detalicznych odnotowuje straty w wyniku handlu kontraktami CFD u niniejszego dostawcy. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Pulpit

JNJ

226.1

-1.8%↓

ABT

92.77

-3.36%↓

MDT

82.53

-3.2%↓

A

122

+0.95%↑

VEEV

167.85

-0.65%↓

JNJ

226.1

-1.8%↓

ABT

92.77

-3.36%↓

MDT

82.53

-3.2%↓

A

122

+0.95%↑

VEEV

167.85

-0.65%↓

JNJ

226.1

-1.8%↓

ABT

92.77

-3.36%↓

MDT

82.53

-3.2%↓

A

122

+0.95%↑

VEEV

167.85

-0.65%↓

JNJ

226.1

-1.8%↓

ABT

92.77

-3.36%↓

MDT

82.53

-3.2%↓

A

122

+0.95%↑

VEEV

167.85

-0.65%↓

JNJ

226.1

-1.8%↓

ABT

92.77

-3.36%↓

MDT

82.53

-3.2%↓

A

122

+0.95%↑

VEEV

167.85

-0.65%↓

Strona główna・Stock List・Seres Therapeutics Inc
Search

Seres Therapeutics Inc

Closed

SectorHealthcare

8.5 -3.74

Buy

Price update 21 kwi 2026, 19:59 UTC

BuySell

Overview

Share price change

24h

Current

Min

8.46

Max

8.99

Key metrics

By Trading Economics

Income

-24M

-15M

Sales

87K

438K

P/E

Sector Avg

13.969

60.328

EPS

-1.76

Profit margin

-3,501.142

Employees

66

EBITDA

-27M

-17M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+134.9% upside

Dividends

By Dow Jones

Next Earnings

6 maj 2026

Market Stats

By TradingEconomics

Market Cap

1.4M

86M

Previous open

12.24

Previous close

8.5

News Sentiment

By Acuity

20%

80%

44 / 348 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

N/A / 9.31 Support & Resistance

Seres Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

12 lut 2026, 13:08 UTC

Major Market Movers

Seres Shares Down After Co Pauses Drug Development, Lays Off Workers

DJ

Read

Peer Comparison

Price change

Seres Therapeutics Inc Forecast

Price Target

By TipRanks

134.9% upside

12 Months Forecast

Average 21 USD  134.9%

High 22 USD

Low 20 USD

Based on 2 Wall Street analysts offering 12 month price targets forSeres Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

1

Buy

1

Hold

0

Sell

Based on 2 analysts giving stock ratings to Seres Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

N/A / 9.31Support & Resistance

Short Term

Bearish Evidence

Recent bearish events outweigh bullish events.

Intermediate Term

Bearish Evidence

All events are bearish.

Long Term

Bearish Evidence

All events are bearish.

Sentiment

By Acuity

44 / 348 Ranking in Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

JNJ

Johnson and Johnson

226.1

↓-1.8%

ABT

Abbott Laboratories

92.77

↓-3.36%

MDT

Medtronic PLC

82.53

↓-3.2%

A

Agilent Technologies Inc

122

↑ +0.95%

VEEV

Veeva Systems Inc

167.85

↓-0.65%
help-icon Live chat